Literature DB >> 18453370

Comorbidities in chronic obstructive pulmonary disease.

Wissam M Chatila1, Byron M Thomashow, Omar A Minai, Gerard J Criner, Barry J Make.   

Abstract

Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and psychological disorders are commonly reported in patients with chronic obstructive pulmonary disease (COPD) but with great variability in reported prevalence. Tobacco smoking is a risk factor for many of these comorbidities as well as for COPD, making it difficult to draw conclusions about the relationship between COPD and these comorbidities. However, recent large epidemiologic studies have confirmed the independent detrimental effects of these comorbidities on patients with COPD. On the other hand, many of these comorbidities are now considered to be part of the commonly prevalent nonpulmonary sequelae of COPD that are relevant not only to the understanding of the real burden of COPD but also to the development of effective management strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18453370      PMCID: PMC2645334          DOI: 10.1513/pats.200709-148ET

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  117 in total

1.  Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins.

Authors:  P Lind; G Engström; L Stavenow; L Janzon; F Lindgärde; B Hedblad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

2.  Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.

Authors:  J G van Manen; P J Bindels; C J IJzermans; J S van der Zee; B J Bottema; E Schadé
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

3.  Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases.

Authors:  Matthias John; Andre Lange; Soeren Hoernig; Christian Witt; Stefan D Anker
Journal:  Int J Cardiol       Date:  2005-10-19       Impact factor: 4.164

4.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study.

Authors:  L Burdet; B de Muralt; Y Schutz; C Pichard; J W Fitting
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

8.  Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters.

Authors:  Lynn E Eberly; Judith Ockene; Roger Sherwin; Lingfeng Yang; Lewis Kuller
Journal:  Int J Epidemiol       Date:  2003-08       Impact factor: 7.196

9.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

Authors:  F Maltais; A A Simard; C Simard; J Jobin; P Desgagnés; P LeBlanc
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

10.  Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.

Authors:  Harry R Gosker; Mariëlle P K J Engelen; Henk van Mameren; Paul J van Dijk; Ger J van der Vusse; Emiel F M Wouters; Annemie M W J Schols
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

View more
  131 in total

1.  Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study.

Authors:  Yiqing Song; Anna Klevak; Joann E Manson; Julie E Buring; Simin Liu
Journal:  Diabetes Res Clin Pract       Date:  2010-10-06       Impact factor: 5.602

Review 2.  Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging.

Authors:  George R Washko; Grace Parraga; Harvey O Coxson
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

3.  A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.

Authors:  Francesca Polverino; Maria E Laucho-Contreras; Hans Petersen; Vanesa Bijol; Lynette M Sholl; Mary E Choi; Miguel Divo; Victor Pinto-Plata; Alfredo Chetta; Yohannes Tesfaigzi; Bartolomé R Celli; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

4.  Concordance of patients' beliefs about chronic obstructive pulmonary disease, their comorbidities, and their medications.

Authors:  Grace E McInerney; Kimberly Muellers; Rachel O'Conor; Michael S Wolf; Howard Leventhal; Juan P Wisnivesky; Alex D Federman
Journal:  Patient Educ Couns       Date:  2019-11-16

Review 5.  Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery.

Authors:  Isabelle Opitz; Silvia Ulrich
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  Pulmonary hypertension in a stable community-based COPD population.

Authors:  Vadim Fayngersh; Fotios Drakopanagiotakis; F Dennis McCool; James R Klinger
Journal:  Lung       Date:  2011-08-04       Impact factor: 2.584

7.  Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in Smokers.

Authors:  Farbod N Rahaghi; J Michael Wells; Carolyn E Come; Isaac A De La Bruere; Surya P Bhatt; James C Ross; Gonzalo Vegas-Sánchez-Ferrero; Alejandro A Diaz; Jasleen Minhas; Mark T Dransfield; Raúl San José Estépar; George R Washko
Journal:  J Comput Assist Tomogr       Date:  2016 Nov/Dec       Impact factor: 1.826

8.  Anemia prevalence and hemoglobin levels are associated with long-term exposure to air pollution in an older population.

Authors:  Trenton Honda; Vivian C Pun; Justin Manjourides; Helen Suh
Journal:  Environ Int       Date:  2017-01-31       Impact factor: 9.621

9.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

Authors:  Raúl San José Estépar; Gregory L Kinney; Jennifer L Black-Shinn; Russell P Bowler; Gordon L Kindlmann; James C Ross; Ron Kikinis; Meilan K Han; Carolyn E Come; Alejandro A Diaz; Michael H Cho; Craig P Hersh; Joyce D Schroeder; John J Reilly; David A Lynch; James D Crapo; J Michael Wells; Mark T Dransfield; John E Hokanson; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

10.  Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.

Authors:  S Vamsee Raju; Patricia L Jackson; Clifford A Courville; Carmel M McNicholas; Peter A Sloane; Gina Sabbatini; Sherry Tidwell; Li Ping Tang; Bo Liu; James A Fortenberry; Caleb W Jones; Jeremy A Boydston; J P Clancy; Larry E Bowen; Frank J Accurso; J Edwin Blalock; Mark T Dransfield; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.